measures of prenatal brain growth. 13, [15] [16] [17] [18] The most consistently smaller measures of prenatal brain growth have been reported in hypoplastic left heart syndrome (HLHS) and complete transposition of the great arteries (TGA). However, even in these subgroups, findings have not been coherent. 13, 17, 19 Few studies have had the sample size to assess measures of cerebral growth relative to overall growth, 20 and no studies have systematically investigated the impact of potentially important confounders such as congenital syndromes, maternal characteristics, and comorbidities.
We conducted a large nationwide, population-based cohort study including all major subtypes of CHD. We aimed to assess the association between all major subgroups of CHD and proxy measures of prenatal brain growth (head circumference), overall growth (birth weight), and the differences between both measures; the proportionality of the infants. We also assessed the associations between a large number of potential confounders and head circumference at birth by the use of high-quality national registries, through a sibling design and through a comparison with infants with other major birth defects.
Methods

Study Cohort
We identified all infants born alive in Denmark between January 1, 1997, and December 31, 2011, from the Danish Civil Registration System. 21 By the use of the personal identifier used in all Danish nationwide registries, all mothers and newborns were linked to individual-level data from the Danish Medical Birth Registry, 22 the Danish National Patient Registry, 23 and the Danish Central Cytogenetic Registry 24 (for details of the data sources see the online-only Data Supplement). To be eligible, the infants and the mothers had to have unique personal identifiers, and the infants had to be singletons with no malformations of the central nervous system or the skull and have a gestational age at birth within a plausible range of 22 to 45 weeks.
Congenital Heart Defects
Information on the presence of CHD was obtained from the Danish National Patient Registry according to the International Classification of Diseases, Tenth Revision (codes Q20-Q26). In accordance with previous studies, unspecific codes of CHD, codes not related to CHD, and codes of nonstructural CHD were not categorized as CHD. 25, 26 Furthermore, isolated bicuspid aortic valve, isolated patent ductus arteriosus, aortic insufficiency, mitral insufficiency, and minor atrial septal defects, including persistent foramen ovale, were not categorized as CHD. The use of the diagnoses has been validated previously. 25 All Danish children with CHD are diagnosed and treated at 1 of 4 university departments of pediatric cardiology, of which 2 are integral parts of surgical centers. We included diagnoses given at the highest specialist level (highest: surgical contacts; intermediate: admissions to a surgical center without surgery; lowest: admission to another department of pediatric cardiology). CHD was classified into 19 mutually exclusive subgroups (see Table 1 ; for further details, see Table I in the online-only Data Supplement).
Fetal Growth Indices
Infant birth weight and head circumference were identified in the Danish Medical Birth Registry. 22 The recording of both measures has been mandatory at all deliveries in Denmark since 1997. All measurements are recorded by trained midwives immediately after delivery and reported to the register. Gestational age at birth was based on ultrasound measurements in >93% of pregnancies in 2000. 27 Implausible records of gestational age were determined according to the most recent US algorithm (birth weight estimates >5 or <-5 standard deviations from the median in term births and >3 or < -4 standard deviations in preterm births). 28 We relied on estimates based on the last menstrual period when ultrasound estimates were implausible or missing. Implausible recordings of head circumference were identified as values >5 or <-5 standard deviations from the median. We calculated head circumference and birth weight z scores, ie, the deviation from the Danish population mean for a given gestational age at birth expressed as the number of standard deviations.
Covariates
Several covariates were also obtained from the Danish Medical Birth Registry: 22 calendar year, maternal age, prepregnancy body mass index, smoking, parity, and whether the pregnancy was recorded as a high-risk pregnancy during the first trimester (recorded by physicians because of potentially harmful conditions including social problems and drug or alcohol abuse). The origin and sex of the infant was determined by records in the Danish Civil Registration System (for details, see the online-only Data Supplement Material). 21 Information on maternal and infant morbidity was obtained from the Danish National Patient Registry. 23 As in earlier studies, maternal prepregnancy diabetes mellitus was defined as any hospital diagnosis of diabetes mellitus before pregnancy or during the first trimester. 29 Similarly, prepregnancy hypertension was defined as any diagnosis of chronic hypertension before pregnancy onset through the first trimester (for details, see online-only Data Supplement Material).
According to the European Surveillance of Congenital Anomalies (EUROCAT), infant extracardiac malformations were categorized into minor malformations, malformations of the nervous system or the skull, and other major malformations. Syndromes were classified as Down syndrome, 22q11.2 deletion syndrome, other chromosomal syndromes, teratogenic syndromes, and other genetic syndromes (for details see Table II in the online-only Data Supplement). 30 To maximize the detection of chromosomal syndromes, we further identified all individuals with a registered cytogenetic anomaly in the Danish Central Cytogenetic Registry and 2478 tests for 22q11.2 deletion syndrome conducted in infants with CHD.
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Analyses
In the present study, we set out to estimate the association between CHD and indices of fetal growth. In the primary analysis, we compared growth indices between all infants with CHD, subgroups of CHD, and infants from the general population. The main outcome variables were head circumference z score, birth weight z score, and the difference between the 2 measures. The last assesses the proportionality of head circumference relative to birth weight. We conducted crude and adjusted multivariable linear regression, accounting for clusters of children within the mothers by using robust standard errors. Potential confounders included in the analyses were identified by using causal diagrams for observational research, based on a priori knowledge from previous studies. 32 Variables included in the adjusted model were maternal age (continuous), prepregnancy body mass index (continuous), hypertension (yes/no), diabetes mellitus (yes/no), nulliparity (yes/no), smoking (yes/no), infant sex, nonwestern origin (yes/no), major extracardiac malformations (yes/no), 5 categories of infant syndromes (Down syndrome, 22q11.2 deletion syndrome, other chromosomal syndromes, other genetic malformation syndromes, teratogenic syndromes), and whether the pregnancy was identified as a high-risk pregnancy during the first trimester (yes/no). Calendar time was modeled by cubic splines with 3 knots.
The largest proportion of missing values for any covariate was 3.8%, with the exception of body mass index, which has only been available since 2004. According to recent recommendations, missing values were handled by multiple imputation (for details of the multiple imputation approach, see online-only Data Supplement Material: Missing Data and Multiple Imputation). 33 Because the study collected a large number of variables predictive of missing data, the assumption of missing at random was considered fulfilled.
To assess the influence of gestational age at birth, we conducted secondary analyses of the associations between CHD and absolute head circumference and birth weight unadjusted for gestational age, capturing the joint association between CHD, growth, and preterm by guest on http://circ.ahajournals.org/ Downloaded from February 9, 2016 birth. 34 To assess potential unmeasured confounding we conducted several additional secondary analyses. Infants with CHD were compared with a cohort of infants with any other major malformation. To control for unmeasured stable family, maternal, or intrauterine factors, we conducted a sibling analysis, restricting the population to mothers with at least 1 infant with a specific subtype of CHD and at least 1 sibling without CHD. For this analysis, we applied a random-effects mixed model comparing siblings within the same mother. 35 These analyses were adjusted for the same potential confounders as the full population analyses.
We further conducted several preplanned sensitivity analyses. To address the robustness of our results to misclassification of infant syndromes, we conducted analyses after the exclusion of all infants with a syndrome and adjusted the results for minor malformations in the infant. To detect a possible effect of termination of pregnancy on our results, we conducted analyses restricted to infants born before the introduction of a universal ultrasound-screening program. 36 To assess whether the time period influenced the association between CHD and the reported growth indices, we further compared the results from the first half of the study period (1997) (1998) (1999) (2000) (2001) (2002) (2003) with the results from the second half of the study period (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) . Because earlier studies pointed toward the third trimester as the main time window of restricted growth in CHD fetuses, 7 we further restricted the analyses to term births only (>37 weeks). To address any possible diagnostic misclassification, we restricted the analyses to infants with surgical codes corresponding to the diagnostic codes. Finally, we repeated the main analysis as a complete case analysis, only including infants with complete data on all covariates.
The study was approved by the Danish Data Protection Agency (J.nr. 2013-41-1689). No informed consent was required for this registry-based study.
Results
The study included 924 422 infants of which 5519 were registered with CHD (see Figure 1 ). Maternal and infant characteristics are listed in Table 2 according to the presence of CHD. The frequencies of the different CHD subtypes are presented in Figure 2 along with head circumference and birth weight z scores.
Head Circumference
The mean head circumference at birth in the population was 35.1 cm. Adjusted for potential confounders, the mean z-score difference between all infants with CHD and the general population was -0.10 (95% confidence interval [CI], -0.13 to -0.08; see Figure 2 ). Several subtypes of CHD were associated with markedly smaller head circumference z scores, including HLHS, other single-ventricle defects (SVDs), TGA, tetralogy of Fallot (TOF), atrioventricular septal defects, common arterial trunk (CAT), anomalous pulmonary venous return (APVR), other combined severe defects, and major ventricular septal defect (VSD), as well. After adjustment for potential confounders, any CHD was associated with a difference in mean absolute head circumference of -0.6 cm (95% CI, -0.6 to -0.5) in comparison with the general population (for subgroup estimates, see Table  III in the online-only Data Supplement). After additional adjustment for gestational age, the largest differences were -0.7 cm (95% CI, -0.9 to -0.5) in TOF, -0.6 cm (95% CI, -1.1 to -0.1) in CAT, and -0.6 cm in HLHS (95% CI, -0.9 to -0.3).
Birth Weight
The mean birth weight in the population was 3530 g, and 955 (17%) of the infants with CHD were small for gestational age. Adjusted for potential confounders the mean z-score difference was -0.17 (95% CI, -0.20 to -0.14; see Figure 2 ). This difference was more pronounced in infants with HLHS, other SVDs, TOF, aortic stenosis, CAT, double outlet right ventricle, APVR, pulmonary atresia, other severe defects, and major atrial septal defects and VSDs. After adjustment for potential confounders, the presence of any CHD was associated with a difference in mean absolute birth weight of -218 g (95% CI, -236 to -201) in comparison with the general population (see Table III in the online-only Data Supplement). After additional adjustment for gestational age, the largest differences were -231 g (95% CI, -291 to -171) in infants with TOF, -211 g (95% CI, -366 to -57) in double-outlet right ventricle, and -204 g (95% CI, -277 to -131) in other SVDs.
The Difference in z Scores
Overall, CHD was associated with larger head circumference in comparison with birth weight z scores, 0.07 (95% CI, 0.05-0.10; see Figure 3 ). Major atrial septal defects, and major and minor VSDs, pulmonary stenosis, and combinations of these defects, as well, were associated with larger head circumference z scores in comparison with birth weight. Only infants with TGA had smaller head circumference z scores relative to birth weight.
Additional Analyses
When the reference group was restricted to siblings only, the estimates, in general, were similar to the main analyses. Only the associations between other SVDs and APVR and head circumference at birth were attenuated (see Table IV in the online-only Data Supplement). Again, only TGA was associated with smaller head circumference in comparison with birth weight. Furthermore, the results remained similar in all subgroups, when all other infants with major extracardiac birth defects were used as the reference (see Table V in the online-only Data Supplement), when all children with a syndrome were excluded (see Table VI in the online-only Data Supplement), and after additional adjustment for the presence of any minor malformation (see Table VII in the online-only Data Supplement), as well, when the analyses were restricted to infants born before routine ultrasound screening, and restricted to infants with surgical codes corroborating the International Classification of Diseases, Tenth Revision codes only. Furthermore, we found no substantial differences in the estimates over time in comparison with the first half of the study period to the second half of the study period. The results restricted to term births were highly consistent with the main analyses. The results from the complete case analysis were also consistent with the results of the main analyses (see Table  VIII in the online-only Data Supplement). Figure 4 shows the associations between covariates of common interest and head circumference z scores. All potential confounders included in the model were associated with the outcomes, with the exception of other genetic malformation syndromes.
Potential Confounding Factors
Discussion
This is the first population-based, nationwide study to investigate the association between all major subtypes of CHD and indices of fetal cerebral growth. Overall, mean head circumference was only slightly smaller in children with CHD. However, several subtypes of CHD were associated with even smaller head circumferences, including HLHS, other SVDs, TGA, TOF, atrioventricular septal defects, CAT, APVR, other severe defects, and major VSDs. It is noteworthy that aortic stenosis, coarctation of the aorta, interrupted aortic arch, pulmonary atresia, pulmonary stenosis, minor VSDs, and other less severe defects were not clearly associated with smaller head circumference. Overall, birth weight z score was modestly smaller than head circumference z score in all children with CHD. With the exception of TGA, all the subtypes associated with smaller head circumference were also associated with smaller birth weight. Most subtypes of CHD were not associated with any noticeable differences between head circumference and birth weight, ie, the infants were symmetrically small. Only TGA was associated with disproportionately smaller head circumference relative to birth weight. Major VSDs and other less severe defects were associated with increased head circumference relative to birth weight, a pattern commonly associated with fetal brain sparing attributable to placental disease. 37 A number of studies have assessed the association between CHD and measures of prenatal cerebral growth including fetal MRI studies, 7 prenatal ultrasound measurements, 13 and head circumference at birth. 15 With few exceptions, 19, 38 all studies found an association between CHD and smaller measures of prenatal cerebral growth. Because of small sample sizes some studies were forced to treat CHD as a single entity 7 or applied less well-defined subgroups. 16 Based on smaller samples, earlier studies mainly reported smaller measures of cerebral growth in HLHS, TGA, and TOF. We confirm these associations.
This study further highlights that smaller head circumference may not be related to left ventricular outflow tract Figure 2 . Associations between subtypes of congenital heart defects and the difference in mean head circumference and birth weight z scores in 924 422 liveborn singleton infants, Denmark, 1997 to 2011. Adjusted: Estimates were adjusted for infant sex, origin, major extracardiac malformations, categories of infant syndromes, maternal prepregnancy body mass index, hypertension, diabetes mellitus, parity, smoking, age, care for high-risk pregnancy, and birth year. The comparison group of infants without any CHD consisted of 918 903 infants in all analyses. CI indicates confidence interval; and No., numbers of exposed infants.
by guest on http://circ.ahajournals.org/ Downloaded from obstructions per se, but only to HLHS, ie, complete obstruction of the left ventricular outflow tract, a credible cause of decreased cerebral oxygen delivery, 14 and neither to isolated aortic stenosis nor to coarctation of the aorta. Also, a trend toward an association between interrupted aortic arch and smaller head circumference in the main analyses disappeared after exclusion of all known syndromes and in the sibling analyses, as well (see Tables IV and VI in the online-only Data Supplement). Furthermore, neither isolated pulmonary stenosis nor pulmonary atresia (excluding SVDs) was associated with smaller head circumference. This finding is in accordance with a previous study demonstrating indicators of increased cerebral blood flow in fetuses with right-sided outflow tract obstructions relative to normal fetuses and fetuses with HLHS. 39 Moreover, we identified defects not previously associated with decreased measures of prenatal cerebral growth, including APVR, major VSDs, and CAT. This is in accordance with an earlier study showing no difference in newborn head circumference between infants with major VSDs and more severe types of CHD. 40 Studies on the proportionality of prenatal cerebral growth relative to overall growth have been sparse, and the results have been inconsistent and subject to considerable statistical imprecision. 13, 15 We found a clear association between TGA and disproportionately smaller head circumference at birth. No other subtypes were associated with disproportionately smaller head circumference, as previously suggested in other studies of TOF, HLHS, or aortic arch hypoplasia. 13, 15, 20, [41] [42] [43] We found disproportionately larger head circumferences relative to birth weight in major VSDs and other less severe subtypes of CHD. No previous studies have reported such associations.
Fetal circulatory anomalies, caused by CHD per se, have long been hypothesized to influence fetal growth. Ultrasound studies have demonstrated brain sparing in fetuses with CHD, 13, 16, 17, 19, 42, 43 and MRI studies have demonstrated decreased fetal cerebral volume before birth. 7, 14 Recently, measures of fetal cerebral oxygenation were directly linked to prenatal brain volume. 14 In accordance with our results, only TGA seemed to be associated with a strict, isolated decrease in cerebral oxygenation. In addition, fetuses with either TOF or SVDs (including HLHS) showed indications of both reduced combined ventricular output and decreased placental oxygen delivery to the fetus (reduced umbilical venous flow and oxygen saturation), which may indicate placental dysfunction. Furthermore, regarding HLHS it may be speculated that nonsyndromic genetic variants might contribute to the lower mean birth weight z score, because the etiologically related lesion, aortic stenosis, was also associated with a lower mean birth weight z score.
Our study raises the possibility that impaired fetal cerebral growth may only be an isolated cerebral phenomenon in infants with TGA, whereas overall growth of the infant may be influenced by other mechanisms in all other major subtypes of CHD. We further demonstrate that isolated outflow tract obstructions may not impair fetal growth per se, unless associated with single-ventricle physiology or complete obstruction of the aortic outflow tract in HLHS. Subtypes of CHD unlikely to cause altered cerebral oxygenation or flow per se, counting major VSDs and isolated APVR, were associated with markedly smaller head circumferences at birth. Thus, prenatal cerebral growth impairment in CHD may possibly be divided into 3 different pathophysiological groups: (1) CHDs in which isolated specific cerebral hypooxygenation may be the most plausible cause, counting only TGA; (2) CHDs in which cerebral hypo-oxygenation combined with additional mechanisms may be the most plausible causes, including most of the subtypes mentioned above; and (3) CHDs in which the most plausible explanations are shared genetic, environmental, or placental causes of CHD and impaired overall growth, including major VSDs and possibly APVR.
The limitations to observational research, in general, also apply to this study. There may have been unmeasured confounders not accounted for. We included several potential confounders of the relationship between CHD and fetal growth indices, all of which should probably be considered in future research of prenatal and perinatal cerebral growth measures. Furthermore, the robustness of our results when changing the reference group to infants with other major birth defects or siblings of the infants with CHD was reassuring. Thus, small head circumference at birth seems to be a unique feature of infants with CHD, even in comparison with infants who have other major birth defects. The possibility to perform a sibling comparison study holds the potential to control for time stable factors. 35 Thus, unmeasured confounding is unlikely to explain our findings.
The risk of misclassification is always present. However, a high degree of diagnostic validity concerning CHD in the Danish National Patient Registry has previously been demonstrated, and the results were consistent in the sensitivity analysis restricted to infants with complete agreement between diagnostic and surgical codes. 25 
Figure 4.
Associations between selected covariates and the adjusted mean difference in head circumference z score in 924 422 liveborn infants, Denmark, 1997 to 2011. Adjusted: All estimates were adjusted for: infant subtypes of congenital heart defects, sex, origin, major extracardiac malformations, categories of infant syndromes, maternal prepregnancy body mass index (BMI), hypertension, diabetes mellitus, parity, smoking, age, care for high-risk pregnancy, and birth year. CI indicates confidence interval. by guest on http://circ.ahajournals.org/
Downloaded from
Because of the high quality of the Danish Medical Birth Registry, the Danish Central Cytogenetic Registry, the Danish National Patient Registry, and the Danish Civil Registration System, we expect the misclassification of the remaining covariates to be negligible (for details see online-only Data Supplement Material). [21] [22] [23] [24] The outcome assessment was effectively blinded to the status of CHD in most cases, because birth defect screening was only gradually implemented from 2004 and onwards. Any misclassification of the outcome would thus be expected to be nondifferential, which may have attenuated our results. A strong point of the present study is that we did not rely on self-reported measures. Previous studies have shown high correlations between head circumference at birth and both brain weight and brain volume, and thus head circumference at birth is considered to be a useful proxy for cerebral size. [44] [45] [46] A previous MRI study reported an increased prevalence of ventriculomegaly and increased extraaxial spaces in fetuses with CHD, 47 and thus an extrapolation from a difference in head circumference at birth to a difference in cerebral size may underestimate the actual difference. Standardization by gestational age at birth may in some cases induce spurious associations. 34 However, judged by the comparison of the z score standardized by gestational age and the absolute differences unadjusted for gestational age at birth, this was not the case. Furthermore, all studies of multiple subtypes of CHD, ie, studies capturing a greater part of the heterogeneity in CHD, inherently contain multiple comparisons.
Further limitations of the present study are the lack of measures of brain maturity and the lack of longitudinal measurements to assess fetal growth. Unfortunately, to our knowledge, this information is not currently available for large-scale population-based studies of CHD.
We included all singleton live births during the study period, nationwide. Thus, selection bias attributable to lack of participation or dropout is not an issue in this study. However, both CHD and fetal growth restriction may be independent risk factors of fetal death, and because the outcomes were only available in live births, this may theoretically have attenuated our results slightly. 48 This concern was addressed in the analyses restricted to a time period when termination of pregnancy because of CHD was rare. The results were unchanged after this restriction. A potential selection introduced by missing data was handled by multiple imputation under a plausible assumption of missing at random.
Summing up the major limitations of this study, the estimates may in some cases be considered conservative, but the limitations do not explain the reported associations.
Future studies should address the possible mechanisms of impaired prenatal growth in the different subgroups of CHD. Further MRI studies are needed especially to clarify whether specific subgroups are associated with isolated cerebral hypoxia, or whether growth restriction may in some instances be attributable to noncardiac causes, such as placental insufficiency or shared genetic causes of growth impairment and CHD. Clarifying the causes of prenatal cerebral growth impairment may be of importance to identify children with CHD likely to benefit from therapy such as, for example, maternal hyperoxygenation.
14 Further studies are also needed to establish the association between subtypes of CHD, perinatal and prenatal factors on one side and long-term neurodevelopmental outcomes on the other side. To date, only a few studies have followed children with specific subtypes of CHD to investigate the long-term risk of neurodevelopmental disorders. 6 In summary, we identified several subtypes of CHD associated with smaller measures of prenatal cerebral growth, some of which have not previously been described. These defects include major VSDs, APVR, and CAT. Thus, even in surgically treated VSDs, an increased incidence of neurodevelopmental disorders may be attributed to prenatal or unknown genetic factors. 10, 49, 50 Only infants with TGA had disproportionately smaller head circumferences relative to birth weight. We further identified several potential confounders to be considered in future studies of CHD and measures of prenatal cerebral growth. 
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CLINICAL PeRSPeCTIveS
Congenital heart defects are the most common major birth defects worldwide, present in 6 per 1000 live births, and a leading cause of neonatal mortality. During the past decades survival has improved greatly and it has become clear that children with congenital heart defects are prone to neurodevelopmental disorders. These disorders occur in up to 50% of the children, but the explanation for this association remains to be fully understood, and the search for the explanation has recently extended into fetal life. The American Heart Association has acknowledged small head circumference as one of the few well-established risk factors for impaired neurodevelopment in children with congenital heart defects. Measures of reduced prenatal cerebral growth have consistently been associated especially with an increased risk of neurodevelopmental disorders in childhood. The present study includes >5500 infants with congenital heart defects, and it represents the first populationbased, nationwide study to examine the association between congenital heart defects and measures of prenatal cerebral growth (head circumference at birth). This allowed the authors to evaluate the association in an unprecedented number of subgroups of congenital heart defects, and the impact of several previously uninvestigated confounders of the association, as well. The study identified several subgroups of congenital heart defects that were not previously associated with measures of impaired prenatal growth. This work will provide an important contribution to the existing knowledge on congenital heart defects and the prenatal origins of neurodevelopmental disorders in this large group of children.
Vibeke E. Hjortdal and John R. Østergaard Tables   Page 7  Table S1 . Codes Used To Identify Congenital Heart Disease Subgroups Page 10 and onwards). The high validity of the registration of maternal parity and gestational age during the study period has been confirmed. 5, 6 A validation report by the Danish National Board of Health further confirmed the high validity of the registration of birth weight and birth head circumference. 
ICD -10 Codes Used to Identify Subtypes of Congenital Heart Disease
When an individual was assigned more than one diagnosis, we only accepted the most severe diagnosis. All diagnoses were classified into highest, intermediate, and lowest severity according to the European Surveillance of Congenital Anomalies (EUROCAT) groups of severity. 12 Diagnoses not per se included in the EUROCAT severity groups, but generally assumed to be minor or ill defined, were included in the lowest severity group (see table S1, other minor defects).
Diagnoses belonging to a higher severity group excluded all diagnoses belonging to lower severity groups. This ensured that no individuals with a severe heart defect were counted as having a less severe lesion. Individuals assigned to more than one diagnosis within the same severity group were assigned to the categories other severe defects or other minor defects. This ensured that the diagnostic subgroups represented isolated lesions rather than combinations of lesions. Due to low numbers, several isolated subgroups with less than 33 individuals were assigned to the categories other severe defects or other minor defects.
In accordance with previous studies the following codes were not categorized as CHD: unspecific codes (Q20.9, Q21.9, Q22.9, Q23.9, Q24.9, Q25.9, Q26.9), codes not related to CHD (Q26.1, Q26.5, Q26.6), and codes of nonstructural CHD (Q24.6). 13 Table S1 .
ICD-10 Codes Used to Identify Extracardiac Birth Defects and Syndromes
All categories of birth defects and congenital syndromes were defined according to the European Surveillance of Congenital Anomalies (EUROCAT) classification system for subgroups of congenital anomalies. 15 Some minor inconsistencies between the British Pediatric Association ICD-10 applied by EUROCAT and the Danish version of ICD-10 were handled according to earlier Danish studies on birth defects (see Table S2 ). 16 All subgroups of malformations are shown in Table S2 . Minor malformations include defects of lesser medical importance such as cryptorchidism, torticollis, or protuberant ears. 15 Congenital malformations of the nervous system include degrees of anencephaly, encephalocele, hydrocephalus, neural tube defects, and other malformations of the brain. defects, defects of the digestive system, as well as all remaining major birth defects.
ICD-10 Codes Used to Identify Maternal Medical Conditions
In accordance with earlier studies pre-pregnancy diabetes was defined as any diagnosis of diabetes prior to the current pregnancy or during the first trimester of the actual pregnancy (ICD10: E10-14, O:24; ICD8: 249-250, 63474, Y6449). 16 We likewise defined pre-pregnancy hypertension as any diagnosis of chronic hypertension prior to pregnancy or during the first trimester of the actual pregnancy (ICD-10: I10-11, O10-11; ICD-8: 40) and further included any diagnoses of pregnancy related hypertension during the first trimester of the actual pregnancy (ICD-10: O13-16). This coding procedure ensures a more complete registration of these chronic disorders, relying on lifetime diagnoses. The restriction to diagnoses given prior to or during the first trimester effectively separates gestational diabetes and gestational hypertension (often less severe conditions) from the chronic conditions. The receipt of a diagnostic code of clinical care for high risk pregnancy during the first trimester (ICD-10: Z35), is coded due to several potentially detrimental conditions during early pregnancy including social problems and drug or alcohol abuse before or during pregnancy. 16 Thus, the possibility to rely on all maternal diagnoses during the entire life course of the mothers prior to the current pregnancy would have counteracted the risk of misclassification of maternal diabetes and hypertension, and we expect to have captured all severe conditions since they inevitably lead to hospital contacts. Further, any misclassification is likely to be non-differential in relation to CHD since we only accepted diagnoses prior to the completion of the first trimester of pregnancy.
Definition of Nonwestern Origin: Parental Citizenships and Nationalities
Earlier studies have established an association between nonwestern parental origin and indices of fetal growth in the Danish population. 17 North America (Canada, the USA), and Australia (Australia, New Zealand).
Missing Data and Multiple Imputation
According to recently published guidelines, missing values were handled by multiple imputation. We were able to identify a number of missing data mechanisms, leading to the identification of several variables that were all confirmed to be predictors of missing data. Mechanisms predicting missing registration of the study variables were the presence of medical conditions in either the infant (prenatal diagnosis of a malformation, asphyxia at birth, neonatal death, neonatal admission to an intensive care unit, abnormal fetal presentation, need for neonatal respirator treatment, need for continuous positive airway pressure treatment, premature birth), or the mother (need for cesarean section, placental abruption, placenta previa, other placental anomalies, premature rupture of membranes, preeclampsia, polyhydramnios, need for labor induction, need for vacuum extraction, cephalopelvic disproportion). Apart from this, home birth was a predictor of missing registrations.
Considering the large amounts of detailed information gathered on the missing data mechanisms we considered the missing at random assumption to be fulfilled.
In accordance with recent recommendations we imputed 100 datasets (exceeding or equal to the percentage of incomplete cases). 19 Imputations were carried out in STATA 13 using chained equations. Binary variables were modeled by the logit function and continuous variables by interval censored linear regression (ensuring biologically plausible values). BMI was skewed to the right, and according to recommendations, transformed to normality by a shifted-log transformation. 19 The observed and imputed values were comparable. According to guidelines, we included all of the above mentioned variables predictive of missing values, as well as all variables in the statistical models. 
Q258, Q268
Severity: Highest corresponds to EUROCAT severity group I, intermediate corresponds to
EUROCAT severity group II, lowest corresponds to EUROCAT severity group III. ICD-10:
International Classification of Diseases, the tenth revision. Surgeries: surgical codes according to the Nordic Classification of Procedures. *Hypoplastic left heart syndrome excluded a diagnoses of other single ventricle defects. Other single ventricle defects were defined as either a relevant diagnostic code or a code of single ventricle surgery. †When both tetralogy of Fallot and pulmonary atresia were diagnosed in the same individual, the lesion was categorized as tetralogy of Fallot. ‡To separate major ventricular septal defects and major atrial septal defects from minor types, these defects were defined as both an isolated diagnostic code and an appropriate surgical code. Major atrial septal defects included primum atrial septal defects. §Due to the large size of the group, combinations of septal defects and pulmonary stenoses were categorized together rather than as other minor defects. ||Other 
